Impact Factor
3.78
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.20
502 total citations
h5-index
33
h5 depth signal
Cited share
81.0%
81 of 100
Total citations
502
Citation footprint
Metric signal
4.86
External metric anchor
Self-citation
0.4%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
142
United States
89
Iran
68
Australia
49
Italy
43
Citing Fields of Research
Neurosciences
242
Neurodegenerative Disorders
166
Brain Neurological Disorders
73
Psychiatry
50
Nervous System Disorders
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,501
Articles tracked across the journal lifetime
Indexed publication set
100
81 cited publications
Last 12 months
52
4.7 publications/month
Open access share
86.5%
45 OA publications in the last year
Leading citing country
China
142 citing publications
Leading citing field
Neurosciences
242 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v4n1,Jan.-Mar. 1993-
v4n1,Jan.-Mar. 1993-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurosciences
Neurodegenerative Disorders
Brain Neurological Disorders
Noncoding RNA
Psychiatry
Broad Categories
Neurology
Neurosciences
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Vascular Disorders
Nervous System Disorders
MeSH Descriptors
Neurosciences
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1515/revneuro-2026-0155
Open DOI
Interpreting peripheral immune phenotypes in Parkinson’s disease: an immune-context framework for biomarker qualification
Peripheral immune alterations are widely reported in Parkinson’s disease (PD), but their biological meaning and clinical utility remain uncertain because circulating immune profiles are shaped by aging, latent infection, medication expos...
02
DOI 10.1515/revneuro-2026-0121
Open DOI
Monoamine receptors of intrinsic spinal neurons and their role in mammalian locomotor control: from physiology to pathology
Locomotor impairment is one of the most devastating consequences of spinal cord injury (SCI) and cannot be adequately overcome by existing rehabilitation methods. Numerous studies in spinalized mammals have demonstrated that serotonin, d...
03
DOI 10.1515/revneuro-2026-0136
Open DOI
Microglial lipid metabolism in perioperative neurocognitive risk: aging-related priming, organelle crosstalk, and lipid-redox injury
Perioperative neurocognitive disorders (PND) are clinically important complications in older surgical patients, but broad neuroinflammatory models do not fully explain age-related susceptibility or failed recovery. Aging alters microglia...
04
DOI 10.1515/revneuro-2026-0134
Open DOI
Non-invasive neuromodulation in Alzheimer’s disease: toward brain–heart coupling as a candidate framework for biomarker-guided adaptive intervention
Alzheimer’s disease (AD) has entered an era of biologically informed, disease-modifying therapy, yet durable clinical benefit remains limited, highlighting the need for complementary interventions. Noninvasive neuromodulation has emerged...
05
DOI 10.1515/revneuro-2026-0088
Open DOI
A review on diffusion tensor imaging–based comprehensive intelligent diagnosis of Alzheimer’s disease
AI-assisted early diagnosis of Alzheimer’s disease (AD) has substantial clinical value, and diffusion tensor imaging (DTI), which captures white matter microstructural alterations, has considerable potential across the AD continuum. Howe...
06
DOI 10.1515/revneuro-2026-0104
Open DOI
Central nervous system involvement of hantaviruses: clinical presentations, neuroimaging findings, and current implications
Because of their involvement in outbreaks, hantaviruses as emerging zoonotic diseases have been regarded a public health issue. Recent reports have identified CNS symptoms of hantavirus infection, although the data are still relatively s...
07
DOI 10.1515/revneuro-2026-0087
Open DOI
Periodic EEG: clinical settings, in vitro models, and potential mechanisms
Periodic complexes occur in the electroencephalogram (EEG) during a number of pathological conditions, often having a poor prognosis (Kuroiwa and Celesia 1980). The contexts in which periodic EEGs occur generally fall into three major ca...
08
DOI 10.1515/revneuro-2026-0110
Open DOI
BDNF-related brain–liver communication in metabolic syndrome: implications for anxiety and depression
Metabolic syndrome is frequently accompanied by anxiety and depression, suggesting interactions between metabolic dysfunction and affective regulation. Brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin r...
09
DOI 10.1515/revneuro-2026-0098
Open DOI
Noncoding RNAs in epilepsy: from molecular mechanisms to clinical translation
Epilepsy comprises a heterogeneous group of brain disorders in which recurrent seizures arise from dynamic interactions among neuronal hyperexcitability, glial activation, neuroinflammation, vascular dysfunction, and maladaptive circuit ...
10
DOI 10.1515/revneuro-2026-0129
Open DOI
Glymphatic-meningeal lymphatic dysfunction drives remote organ injury after aneurysmal subarachnoid hemorrhage: a unified neuroimmune framework and time-stratified therapeutic roadmap
Aneurysmal subarachnoid hemorrhage (aSAH) confers substantial mortality and morbidity driven not only by primary brain injury but also by systemic remote organ complications across the pulmonary, cardiac, renal and gastrointestinal syste...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.